Chromosomal abnormalities are major causes of perinatal death and childhood handicap. Consequently, the detection of chromosomal disorders constitutes the most frequent indication for invasive prenatal diagnosis. However, invasive testing, by amniocentesis, chorionicvillus sampling (CVS) or cordocentesis, is associated with a risk of miscarriage of about 1% and therefore these tests are carried…
TREAT-NMD (Transnational Research in Europe - Assessment and Treatment of Neuromuscular Diseases) is a European Union funded Network of Excellence launched on January 1st 2007 with the aim of improving treatment and finding cures for patients with neuromuscular diseases.
Human genetic testing centre gains international quality accreditation.
By Professor Gustav Steinhoff MD, director of the Department for Cardiac Surgery, and Christof Stamm MD, co-ordinator of clinical studies, at Rostock University, Germany
While today prenatal diagnostics provides a wide range of possibilities, prenatal therapy is still rather limited.